Health Care Revance to be acquired, taken private in $924M deal Hannah Herner Updated Sep 25, 2024 Botox competitor saw steady decline in stock price over past year
Health Care Featured Once surging Revance sees gradual fade Hannah Herner Updated Jul 1, 2024 Nashville-based aesthetics company suffers due to lack of consumer spending, analyst said
Health Care Botox maker’s lawsuit against Nashville competitor continues Hannah Herner Updated Jan 19, 2024 Allergan alleges former employees brought trade secrets to Revance
Health Care Revance Therapeutics grows Nashville office, therapeutic pipeline Hannah Herner Updated Sep 22, 2023 Area biotech company gaining speed one year after Daxxify FDA approval
Health Care Health Care Notes: Health Care Council announces conference lineup Hannah Herner Updated Jan 12, 2024 Also: Local aesthetics company moves into therapeutics; Nashville General enlists Oracle
Health Care Earnings Roundup: SmileDirectClub, Revance fall short in Q2 Hannah Herner Updated Aug 9, 2023 Also: Cumberland Pharmaceuticals sees shares rise following positive reportÂ
Health Care Earnings roundup: Clover, SmileDirect struggle while Revance grows Hannah Herner Updated May 22, 2023 Two local companies face threats of Nasdaq delisting
Health Care Local biotech company sees 54 percent stock jump Hannah Herner Updated Jan 20, 2023 Revance announced preliminary results on its Botox-like neuromodulators
